trial · primary record
Tranexamic acid
Abortion
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2023-07-27 |
| Primary endpoint | Intervention to control blood loss |
| Registry ID | NCT04651166 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:34.994Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04651166
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Tranexamic Acid · approval
- Tranexamic acid · compound